Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Johnson & Johnson : Investigation Opened Into Death of Woman After Receiving Covid-19 Vaccine

07/28/2021 | 06:06am EDT

The Ministry of Health has opened an investigation into the death of a young woman in Marrakech on Monday after receiving a dose of the COVID-19 vaccine.

After receiving doses of the Johnson & Johnson vaccine, a vaccination operation has targeted, since last Sunday, some 5,000 people, including tourism employees in Casablanca, Marrakech and Agadir, the ministry of Health said Tuesday in a statement.

However, the services of the ministry were informed of the death of a 33-year-old woman at the Bab Ighli Cultural Center in Marrakech, after receiving a dose of the vaccine on Monday, and of the fainting of one of her colleagues, the source added.

The ministry says it has immediately opened an investigation and sent a commission to Marrakech to investigate the incident.

The dedicated pharmacovigilance system has ensured, since the launch of the national vaccination operation, the monitoring of any side effects or incidents coinciding with this operation, the ministry pointed out, adding that it will publish the results of the investigation.

Copyright Maghreb Arabe Presse. Distributed by AllAfrica Global Media (allAfrica.com)., source News Service English

All news about JOHNSON & JOHNSON
12:53pJOHNSON & JOHNSON : Unit Collaborates With Persephone Biosciences On Stool Analysis
MT
10:06aShangula Rages Against West's Vaccine Nationalism
AQ
09:55aJOHNSON & JOHNSON : Data Shows COVID-19 Booster Shots 94% Effective Against Moderate to Se..
MT
09:40aToday on Wall Street: Markets at a pivot point
08:27aJOHNSON & JOHNSON : Says New Data Show Booster Shot Increases COVID-19 Protection
MT
08:01aJ&J : Booster dose of its COVID shot prompts strong response
AQ
07:38aJOHNSON & JOHNSON : Says New Data Shows a Booster of its One-Shot Vaccine Increases COVID-..
MT
06:31aJOHNSON & JOHNSON : Announces Real-World Evidence and Phase 3 Data Confirming Strong and L..
PR
05:12aJOHNSON & JOHNSON : COVID-19 Vaccine to Reportedly Arrive in India Next Month
MT
09/20JOHNSON & JOHNSON : The Janssen Pharmaceutical - RYBREVANT (amivantamab-vmjw) Provides Hig..
AQ
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Financials (USD)
Sales 2021 94 407 M - -
Net income 2021 22 809 M - -
Net Debt 2021 1 880 M - -
P/E ratio 2021 19,1x
Yield 2021 2,53%
Capitalization 433 B 433 B -
EV / Sales 2021 4,61x
EV / Sales 2022 4,41x
Nbr of Employees 134 500
Free-Float 84,3%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 164,53 $
Average target price 185,83 $
Spread / Average Target 12,9%
EPS Revisions
Managers and Directors
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON4.54%431 227
ROCHE HOLDING AG10.52%321 941
PFIZER, INC.19.23%247 816
NOVO NORDISK A/S48.69%229 255
ELI LILLY AND COMPANY37.20%210 000
ABBVIE INC.-0.70%188 027